Últimas noticias sobre AMETEK (NYSE:AME) Bolsa

AMETEK

Founded in 1930 and transformed over the decades through the acquisition of dozens of esteemed brands, Ametek owns a collection of over 40 autonomous industrial businesses operating within the research, aerospace, energy, medical, and manufacturing industries. Ametek segments its business into two operating groups: the electronic instruments group and the electromechanical group. The EIG sells a broad portfolio of analytical, test, and measurement instruments, while the EMG sells highly engineered components, interconnects, and specialty metals. The company emphasizes product differentiation and market leadership in the niche markets where it operates.

AMETEK Inc

AME Chain

Amedisys Inc

AMERICAN EAGLE GOLD CORP by AMERICAN EAGLE GOLD CORP.

American Eagle Gold Corp

AMEN PROPERTIES INC by AMEN Properties, Inc.

AMEN Properties Inc

Anteris Technologies Ltd

AMETEK's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AME#NYSE">AME</a>) short percent of float has risen 16.67% since its last report. The company recently reported that it has 2.71 million shares sold short, which is 1.33% of all regular shares that are available for trading. Based on its trading volume, it would take traders 2.0 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>AMETEK Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1748966429_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for AMETEK has grown since its last report. This does not mean that the stock is going to fall in the near-term but traders should be aware that more shares are being shorted.
<h3>Comparing AMETEK's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, AMETEK's peer group average for short interest as a percentage of float is 9.36%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Short Sellers

Short Ideas

Trading Ideas

Looking Into AMETEK's Recent Short Interest

Each week, Benzinga's Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the <a href="https://www.benzinga.com/topic/stock-whisper-index" target="_blank" rel="noreferrer noopener">surface and deserve attention</a>.
Investors are constantly on the hunt for undervalued, under-followed and emerging stocks. With countless methods available to retail traders, the challenge often lies in sifting through the abundance of information to uncover new opportunities and understand why certain stocks should be of interest.
Read Also:&nbsp;<a href="https://www.benzinga.com/trading-ideas/25/05/45171636/exclusive-aprils-20-most-searched-tickers-on-benzinga-pro-where-do-tesla-apple-palantir-nvidia-stocks-rank" target="_blank" rel="noreferrer noopener">EXCLUSIVE: April's 20 Most-Searched Tickers On Benzinga Pro — Where Do Tesla, Apple, Palantir, Nvidia Stocks Rank?</a>
Here&#8217;s a look at the Benzinga Stock Whisper Index for the week ending May 23:
Halozyme Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HALO#NASDAQ">HALO</a>): The biotech company saw increased interest from readers during the week, which comes a couple weeks after first-quarter financial results. The company <a href="https://ir.halozyme.com/news/news-details/2025/HALOZYME-RAISES-2025-FINANCIAL-GUIDANCE-RANGES-AND-REPORTS-STRONG-FIRST-QUARTER-2025-RESULTS/default.aspx">beat </a>analyst estimates for both earnings per share and revenue in the quarter. Halozyme also announced a new $250 million share buyback and raised full-year guidance. The company highlighted three blockbuster brands and four recently launched products. The company sees several growth catalysts coming in the future months through owned drugs and partnerships. Analysts were mixed on the stock after financial results with Morgan Stanley<a href="https://www.benzinga.com/quote/HALO/analyst-ratings"> downgrading the stock</a> and Wells Fargo raising the price target. The stock was up around 5% over the last week, as shown on the <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0523">Benzinga Pro chart</a> below.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0523"><img loading="lazy" decoding="async" width="995" height="501" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/23173420/Screenshot-424.png" alt="" class="wp-image-926666" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/23173420/Screenshot-424.png 995w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/23173420/Screenshot-424-300x151.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/23173420/Screenshot-424-768x387.png 768w" sizes="(max-width: 995px) 100vw, 995px" /></a></figure>
Tradeweb Markets Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TW#NASDAQ">TW</a>): The fixed income trading company saw increased interest from readers during the week. The company <a href="https://investors.tradeweb.com/news-releases/news-release-details/tradeweb-reports-april-2025-total-trading-volume-578-trillion">reported </a>April metrics recently with average daily volume for the month hitting $2.7 trillion, up 38.6% year-over-year. Tradeweb saw several records in the month including average daily volume for US government bonds, municipal bonds, US ETFs and more. Tradeweb analysts have <a href="https://www.benzinga.com/quote/TW/analyst-ratings">raised the price targets</a> on the stock and this one could be one to watch in June with the company presenting at the Piper Sandler conference on June 5. The company's next quarterly results could see strong results and raised guidance if the trends from April continue.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0523"><img loading="lazy" decoding="async" width="997" height="499" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/23173438/Screenshot-425.png" alt="" class="wp-image-926667" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/23173438/Screenshot-425.png 997w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/23173438/Screenshot-425-300x150.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/23173438/Screenshot-425-768x384.png 768w" sizes="(max-width: 997px) 100vw, 997px" /></a></figure>
AMETEK Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AME#NYSE">AME</a>): The autonomous industrial company saw strong interest during the week, likely due to a recently announced acquisition and quarterly financial results. AMETEK's first quarter <a href="https://investors.ametek.com/news-releases/news-release-details/ametek-announces-first-quarter-results-3">saw </a>earnings per share beat analyst estimates, marking more than 10 straight quarters of beats, while sales just missed analyst estimates. The company said it was pleased with the first quarter and despite headwinds like macro uncertainties and tariffs, sees a strong fiscal year. The company also announced it will <a href="https://investors.ametek.com/news-releases/news-release-details/ametek-acquire-faro-technologies">acquire </a>FARO Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FARO#NASDAQ">FARO</a>) at an enterprise value of $920 million. The acquisition will be done using stock and cash and is expected to boost its precision segment. Faro has annual sales of around $340 million. The earnings and acquisition saw interest increase in the company, which puts this one on the watchlist as its operations with autonomous tools could be one of the fast-growing segments.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0523"><img loading="lazy" decoding="async" width="999" height="504" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/23173451/Screenshot-426.png" alt="" class="wp-image-926668" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/23173451/Screenshot-426.png 999w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/23173451/Screenshot-426-300x151.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/23173451/Screenshot-426-768x387.png 768w" sizes="(max-width: 999px) 100vw, 999px" /></a></figure>
Alliant Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LNT#NASDAQ">LNT</a>): The utility company <a href="https://investors.alliantenergy.com/News--Presentations/news/news-details/2025/Alliant-Energy-Announces-First-Quarter-2025-Results/default.aspx">reported </a>first-quarter financial results on May 8 with earnings per share and revenue beating analyst estimates, marking three straight quarters of double beats. The company also reaffirmed its full-year guidance and announced new details on financing plans. The company owns Interstate Power and Light Company and Wisconsin Power and Light Company, providing electric to around one million customers and natural gas to around 430,000 customers in the Midwest. Jeffries <a href="https://www.benzinga.com/quote/LNT/analyst-ratings">upgraded the stock</a> from Hold to Buy after the financial results.
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0523"><img loading="lazy" decoding="async" width="997" height="499" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/23173504/Screenshot-427.png" alt="" class="wp-image-926669" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/23173504/Screenshot-427.png 997w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/23173504/Screenshot-427-300x150.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/23173504/Screenshot-427-768x384.png 768w" sizes="(max-width: 997px) 100vw, 997px" /></a></figure>
Ares Acquisition Corporation II (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AACT#NYSE">AACT</a>): Several SPACs saw increased interest from readers during the week and higher share prices. Ares Acquisition<a href="https://www.benzinga.com/markets/equities/25/04/44809515/george-soros-cathie-wood-backed-autonomous-trucking-firm-kodiak-robotics-set-to-go-public-via-spac-merger-to-tap-4-trillion-market"> announced a merger</a> with autonomous trucking company Kodiak Robotics. Increased interest for the SPAC could be due to the autonomous space seeing a boost from a recent test drive from Aurora and anticipation for Tesla's robotaxi launch in June. Kodiak says it has logged over 2.6 million autonomous driving miles in "real-world conditions." Investors in the company and SPAC merger deal includes Ares, Soros Fund Management and Ark Investments. The merger is expected to be completed in the second half of 2025.  
<figure class="wp-block-image size-full"><a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0523"><img loading="lazy" decoding="async" width="997" height="511" src="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/23173526/Screenshot-428.png" alt="" class="wp-image-926670" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/23173526/Screenshot-428.png 997w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/23173526/Screenshot-428-300x154.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2025/05/23173526/Screenshot-428-768x394.png 768w" sizes="(max-width: 997px) 100vw, 997px" /></a></figure>
Stay tuned for next week's report, and follow Benzinga Pro for all the latest headlines and <a href="https://www.benzinga.com/pro/register?utm_adType=bzprocontent&amp;utm_campaign=14daytrial&amp;utm_ad=0523" target="_blank" rel="noreferrer noopener">top market-moving stories here.</a>
Read the latest Stock Whisper Index reports here:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/trading-ideas/25/04/45029510/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet-62" target="_blank" rel="noreferrer noopener">April 25</a></li>
<li><a href="https://www.benzinga.com/trading-ideas/25/05/45183831/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet-63" target="_blank" rel="noreferrer noopener">May 2</a></li>
<li><a href="https://www.benzinga.com/trading-ideas/25/05/45335286/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet-64" target="_blank" rel="noreferrer noopener">May 9</a></li>
<li><a href="https://www.benzinga.com/trading-ideas/25/05/45482435/benzingas-stock-whisper-index-5-stocks-investors-secretly-monitor-but-dont-talk-about-yet-65">May 16 </a></li>
</ul>
Read Next:
<ul class="wp-block-list">
<li><a href="https://www.benzinga.com/tech/25/04/45112477/exclusive-if-meta-is-forced-to-divest-instagram-whatsapp-or-facebook-43-pick-this-standout" target="_blank" rel="noreferrer noopener">EXCLUSIVE: If Meta Is Forced To Divest Instagram, WhatsApp, Or Facebook, 43% Pick This Standout</a></li>
</ul>

Exclusives

AACT

FARO

HALO

Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet

WIIM

AMPX

ARRY

CHPT

ENVX

FLNC

GNRC

NRGV

POWL

PSIX

SDST

TPIC

Shares of electrical equipment companies are higher after the US and China agreed to a temporary reduction in most tariffs on each other's goods. A reduction in tariffs could alleviate some supply chain concerns and improve macro sentiment as well as demand visibility.

Baird analyst Richard Eastman maintains AMETEK (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AME#NYSE">AME</a>) with a Neutral and lowers the price target from $197 to $190.

News

Price Target

Analyst Ratings

Baird Maintains Neutral on AMETEK, Lowers Price Target to $190

AMETEK, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AME#NYSE">AME</a>) and FARO Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FARO#NASDAQ">FARO</a>) today announced that they have entered into a definitive agreement under which AMETEK will acquire all outstanding shares of FARO Technologies common stock for $44 per share in cash, which represents an approximate 40% premium to FARO's closing price on May 5, 2025. The transaction values FARO at an enterprise value of approximately $920 million. The boards of directors of both companies have unanimously approved the transaction.
Founded in 1981 and headquartered in Lake Mary, Florida, FARO Technologies is a leading provider of 3D measurement and imaging solutions, including portable measurement arms, laser scanners and trackers, software solutions, and comprehensive service offerings. FARO's precision manufacturing and digital reality solutions serve a diverse range of end markets. The company has annual sales of approximately $340 million.

AMETEK And FARO Technologies Have Entered Into A Definitive Agreement Under Which AMETEK Will Acquire All Outstanding Shares Of FARO Technologies Common Stock For $44 Per Share In Cash, Or An Enterprise Value Of ~$920M

AMETEK To Acquire FARO Technologies For $44/Share In $920M Deal, Expanding 3D Measurement Portfolio

Truist Securities analyst Jamie Cook maintains AMETEK (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AME#NYSE">AME</a>) with a Buy and raises the price target from $196 to $200.

Truist Securities Maintains Buy on AMETEK, Raises Price Target to $200

Across the recent three months, 4 analysts have shared their insights on AMETEK (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AME#NYSE">AME</a>), expressing a variety of opinions spanning from bullish to bearish.
The table below offers a condensed view of their recent ratings, showcasing the changing sentiments over the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">1</td>
<td align="right">1</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
In the assessment of 12-month price targets, analysts unveil insights for AMETEK, presenting an average target of $191.0, a high estimate of $201.00, and a low estimate of $170.00. Experiencing a 6.06% decline, the current average is now lower than the previous average price target of $203.33. 
<img src="https://www.benzinga.com/files/images/story/2025/1746216035_0.png" alt="price target chart" />
<h2>Interpreting Analyst Ratings: A Closer Look</h2>
The perception of AMETEK by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
<table>
<thead>
<tr>
<th>Analyst</th>
<th>Analyst Firm</th>
<th>Action Taken</th>
<th>Rating</th>
<th>Current Price Target</th>
<th>Prior Price Target</th>
</tr>
</thead>
<tbody>
<tr>
<td>Deane Dray</td>
<td>RBC Capital</td>
<td>Raises</td>
<td>Outperform</td>
<td>$201.00</td>
<td>$194.00</td>
</tr>
<tr>
<td>Christopher Snyder</td>
<td>Morgan Stanley</td>
<td>Announces</td>
<td>Equal-Weight</td>
<td>$170.00</td>
<td>-</td>
</tr>
<tr>
<td>Jamie Cook</td>
<td>Truist Securities</td>
<td>Lowers</td>
<td>Buy</td>
<td>$196.00</td>
<td>$216.00</td>
</tr>
<tr>
<td>Richard Eastman</td>
<td>Baird</td>
<td>Lowers</td>
<td>Neutral</td>
<td>$197.00</td>
<td>$200.00</td>
</tr>
</tbody>
</table>
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to AMETEK. This information provides a snapshot of how analysts perceive the current state of the company.</li>
<li>Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of AMETEK compared to the broader market.</li>
<li>Price Targets: Analysts navigate through adjustments in price targets, providing estimates for AMETEK's future value. Comparing current and prior targets offers insights into analysts' evolving expectations.</li>
</ul>
Analyzing these analyst evaluations alongside relevant financial metrics can provide a comprehensive view of AMETEK's market position. Stay informed and make data-driven decisions with the assistance of our Ratings Table.
<a href="https://www.benzinga.com/quote/AME/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on AMETEK analyst ratings.</a>
<h2>All You Need to Know About AMETEK</h2>
Founded in 1930 and transformed over the decades through the acquisition of dozens of esteemed brands, Ametek owns a collection of over 40 autonomous industrial businesses operating within the research, aerospace, energy, medical, and manufacturing industries. Ametek segments its business into two operating groups: the electronic instruments group and the electromechanical group. The EIG sells a broad portfolio of analytical, test, and measurement instruments, while the EMG sells highly engineered components, interconnects, and specialty metals. The company emphasizes product differentiation and market leadership in the niche markets where it operates.
<h3>Financial Insights: AMETEK</h3>
Market Capitalization Analysis: The company's market capitalization surpasses industry averages, showcasing a dominant size relative to peers and suggesting a strong market position.
Positive Revenue Trend: Examining AMETEK's financials over 3M reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 1.77% as of 31 December, 2024, showcasing a substantial increase in top-line earnings. When compared to others in the Industrials sector, the company excelled with a growth rate higher than the average among peers.
Net Margin: AMETEK's net margin is impressive, surpassing industry averages. With a net margin of 21.98%, the company demonstrates strong profitability and effective cost management.
Return on Equity (ROE): AMETEK's ROE excels beyond industry benchmarks, reaching 4.03%. This signifies robust financial management and efficient use of shareholder equity capital.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 2.63%, the company showcases effective utilization of assets.
Debt Management: With a below-average debt-to-equity ratio of 0.22, AMETEK adopts a prudent financial strategy, indicating a balanced approach to debt management.
<h2>The Basics of Analyst Ratings</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Analysts may supplement their ratings with predictions for metrics like growth estimates, earnings, and revenue, offering investors a more comprehensive outlook. However, investors should be mindful that analysts, like any human, can have subjective perspectives influencing their forecasts.
Which Stocks Are Analysts Recommending Now?
Benzinga Edge gives you instant access to all major analyst upgrades, downgrades, and price targets. Sort by accuracy, upside potential, and more. <a href="https://www.benzinga.com/premium/ideas/benzinga-edge-checkout/?t=be8be9arja3be22bz21&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Click here to stay ahead of the market</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AMETEK Stock: A Deep Dive Into Analyst Perspectives (4 Ratings)

RBC Capital analyst Deane Dray maintains AMETEK (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AME#NYSE">AME</a>) with a Outperform and raises the price target from $194 to $201.

RBC Capital Maintains Outperform on AMETEK, Raises Price Target to $201

AMETEK (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AME#NYSE">AME</a>) affirms FY2025 Adj EPS guidance from $7.02-$7.18 to $7.02-$7.18 vs $7.08 analyst estimate..

Guidance

AMETEK Affirms FY2025 Adj EPS Guidance of $7.02-$7.18 vs $7.08 Est

AMETEK (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AME#NYSE">AME</a>) reported quarterly earnings of $1.75 per share which beat the analyst consensus estimate of $1.69 by 3.55 percent. This is a 6.71 percent increase over earnings of $1.64 per share from the same period last year. The company reported quarterly sales of $1.73 billion which missed the analyst consensus estimate of $1.74 billion by 0.65 percent. This is a 0.23 percent decrease over sales of $1.74 billion the same period last year.

Earnings

Earnings Beats

Earnings Misses

AMETEK Q1 Adj. EPS $1.75 Beats $1.69 Estimate, Sales $1.73B Miss $1.74B Estimate

AAMI

AAPL

ABNB

ACCO

ADPT

AGCO

AGIO

ALHC

ALKS

ALNY

ALSN

AMGN

AMWL

AMZN

APLE

APTV

ARDX

ARVN

ASND

ASPS

ASUR

ATEC

ATEN

AXTI

BBAI

BIIB

BJRI

BLDR

BMRN

BOOM

BPMC

BRFH

CABO

CARR

CART

CERS

CMLS

COHN

COHU

COLM

COMM

COOK

CRAI

CTRE

CUBE

CWST

DBRG

DINO

DSGR

DUOL

DXCM

ECVT

ELME

Earnings Scheduled For May 1, 2025

AMETEK (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AME#NYSE">AME</a>) is gearing up to announce its quarterly earnings on Thursday, 2025-05-01. Here's a quick overview of what investors should know before the release.
Analysts are estimating that AMETEK will report an earnings per share (EPS) of $1.69.
Investors in AMETEK are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
<h3>Past Earnings Performance</h3>
In the previous earnings release, the company beat EPS by $0.02, leading to a 0.15% drop in the share price the following trading session.
Here's a look at AMETEK's past performance and the resulting price change:

<table>
<thead>
<tr>
<th>Quarter</th>
<th>Q4 2024</th>
<th>Q3 2024</th>
<th>Q2 2024</th>
<th>Q1 2024</th>
</tr>
</thead>
<tbody>
<tr>
<td>EPS Estimate</td>
<td>1.85</td>
<td>1.62</td>
<td>1.64</td>
<td>1.59</td>
</tr>
<tr>
<td>EPS Actual</td>
<td>1.87</td>
<td>1.66</td>
<td>1.66</td>
<td>1.64</td>
</tr>
<tr>
<td>Price Change %</td>
<td>-0.0%</td>
<td>-3.0%</td>
<td>-4.0%</td>
<td>2.0%</td>
</tr>
</tbody>
</table>

<img src="https://www.benzinga.com/files/images/story/2025/1746025274_0.png" alt="eps graph" />
<h3>Performance of AMETEK Shares</h3>
Shares of AMETEK were trading at $167.8 as of April 29. Over the last 52-week period, shares are up 2.0%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. 
<h3>Analyst Observations about AMETEK</h3>
For investors, staying informed about market sentiments and expectations in the industry is paramount. This analysis provides an exploration of the latest insights on AMETEK.
AMETEK has received a total of 3 ratings from analysts, with the consensus rating as Neutral. With an average one-year price target of $187.67, the consensus suggests a potential 11.84% upside.
<h3>Peer Ratings Overview</h3>
In this comparison, we explore the analyst ratings and average 1-year price targets of Vertiv Holdings, Rockwell Automation and Hubbell, three prominent industry players, offering insights into their relative performance expectations and market positioning.
<ul>
<li>Analysts currently favor an Neutral trajectory for Vertiv Holdings, with an average 1-year price target of $106.78, suggesting a potential 36.36% downside.</li>
<li>Analysts currently favor an Neutral trajectory for Rockwell Automation, with an average 1-year price target of $294.36, suggesting a potential 75.42% upside.</li>
<li>Analysts currently favor an Neutral trajectory for Hubbell, with an average 1-year price target of $391.33, suggesting a potential 133.21% upside.</li>
</ul>
<h3>Overview of Peer Analysis</h3>
The peer analysis summary presents essential metrics for Vertiv Holdings, Rockwell Automation and Hubbell, unveiling their respective standings within the industry and providing valuable insights into their market positions and comparative performance.

<table>
<thead>
<tr>
<th>Company</th>
<th>Consensus</th>
<th>Revenue Growth</th>
<th>Gross Profit</th>
<th>Return on Equity</th>
</tr>
</thead>
<tbody>
<tr>
<td>AMETEK</td>
<td>Neutral</td>
<td>1.77%</td>
<td>$644.75M</td>
<td>4.03%</td>
</tr>
<tr>
<td>Vertiv Holdings</td>
<td>Neutral</td>
<td>24.21%</td>
<td>$686.50M</td>
<td>6.45%</td>
</tr>
<tr>
<td>Rockwell Automation</td>
<td>Neutral</td>
<td>-8.33%</td>
<td>$722M</td>
<td>5.32%</td>
</tr>
<tr>
<td>Hubbell</td>
<td>Neutral</td>
<td>-0.85%</td>
<td>$450.60M</td>
<td>6.06%</td>
</tr>
</tbody>
</table>

Key Takeaway:
AMETEK ranks in the middle for revenue growth among its peers. It has the highest gross profit compared to others. AMETEK's return on equity is lower than the top performer but higher than the bottom performer.
<h3>Discovering AMETEK: A Closer Look</h3>
Founded in 1930 and transformed over the decades through the acquisition of dozens of esteemed brands, Ametek owns a collection of over 40 autonomous industrial businesses operating within the research, aerospace, energy, medical, and manufacturing industries. Ametek segments its business into two operating groups: the electronic instruments group and the electromechanical group. The EIG sells a broad portfolio of analytical, test, and measurement instruments, while the EMG sells highly engineered components, interconnects, and specialty metals. The company emphasizes product differentiation and market leadership in the niche markets where it operates.
<h3>Financial Milestones: AMETEK's Journey</h3>
Market Capitalization Analysis: With an elevated market capitalization, the company stands out above industry averages, showcasing substantial size and market acknowledgment.
Revenue Growth: Over the 3 months period, AMETEK showcased positive performance, achieving a revenue growth rate of 1.77% as of 31 December, 2024. This reflects a substantial increase in the company's top-line earnings. As compared to its peers, the revenue growth lags behind its industry peers. The company achieved a growth rate lower than the average among peers in Industrials sector.
Net Margin: AMETEK's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of 21.98%, the company showcases strong profitability and effective cost management.
Return on Equity (ROE): AMETEK's ROE stands out, surpassing industry averages. With an impressive ROE of 4.03%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): AMETEK's ROA stands out, surpassing industry averages. With an impressive ROA of 2.63%, the company demonstrates effective utilization of assets and strong financial performance.
Debt Management: AMETEK's debt-to-equity ratio is below the industry average at 0.22, reflecting a lower dependency on debt financing and a more conservative financial approach.
<a href="https://www.benzinga.com/quote/AME/earnings">To track all earnings releases for AMETEK visit their earnings calendar on our site.</a>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Insights Ahead: AMETEK's Quarterly Earnings

AMETEK (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AME#NYSE">AME</a>) has outperformed the market over the past 15 years by 4.8% on an annualized basis producing an average annual return of 15.51%. Currently, AMETEK has a market capitalization of $38.59 billion. 
Buying $100 In AME: If an investor had bought $100 of AME stock 15 years ago, it would be worth $853.85 today based on a price of $167.24 for AME at the time of writing.
<h3>AMETEK's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1745531128_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $100 In This Stock 15 Years Ago, You Would Have This Much Today

AMETEK (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AME#NYSE">AME</a>) has outperformed the market over the past 15 years by 4.82% on an annualized basis producing an average annual return of 15.06%. Currently, AMETEK has a market capitalization of $36.69 billion. 
Buying $1000 In AME: If an investor had bought $1000 of AME stock 15 years ago, it would be worth $8,279.04 today based on a price of $159.02 for AME at the time of writing.
<h3>AMETEK's Performance Over Last 15 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744902013_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

$1000 Invested In This Stock 15 Years Ago Would Be Worth This Much Today

AMETEK's (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AME#NYSE">AME</a>) short percent of float has fallen 22.76% since its last report. The company recently reported that it has 2.28 million shares sold short, which is 1.12% of all regular shares that are available for trading. Based on its trading volume, it would take traders 1.95 days to cover their short positions on average.
<h3>Why Short Interest Matters</h3>
Short interest is the number of shares that have been sold short but have not yet been covered or closed out. <a href="https://www.benzinga.com/money/how-to-short-a-stock?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">Short selling</a> is when a trader sells shares of a company they do not own, with the hope that the price will fall. Traders make money from short selling if the price of the stock falls and they lose if it rises.
Short interest is important to track because it can act as an indicator of market sentiment towards a particular stock. An increase in short interest can signal that investors have become more bearish, while a decrease in short interest can signal they have become more bullish.
See Also: <a href="https://www.benzinga.com/short-interest?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">List of the most shorted stocks</a>
<h3>AMETEK Short Interest Graph (3 Months)</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1744650026_0.png" alt="short_fig" />
As you can see from the chart above the percentage of shares that are sold short for AMETEK has declined since its last report. This does not mean that the stock is going to rise in the near-term but traders should be aware that less shares are being shorted.
<h3>Comparing AMETEK's Short Interest Against Its Peers</h3>
Peer comparison is a popular technique amongst analysts and investors for gauging how well a company is performing. A company's peer is another company that has similar characteristics to it, such as industry, size, age, and financial structure. You can find a company's peer group by reading its 10-K, proxy filing, or by doing your own similarity analysis.
According to <a href="https://www.benzinga.com/pro/">Benzinga Pro</a>, AMETEK's peer group average for short interest as a percentage of float is 9.07%, which means the company has less short interest than most of its peers.
Did you know that increasing short interest can actually be bullish for a stock? <a href="https://www.benzinga.com/money/how-to-make-money-on-a-short-squeeze?adType=benzinga-insights&amp;ad=short-interest&amp;campaign=wallstreetadvantage">This post by Benzinga Money explains how you can profit from it.</a>
This article was generated by Benzinga's automated content engine and was reviewed by an editor.

Peering Into AMETEK's Recent Short Interest

AMETEK (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AME#NYSE">AME</a>) has been analyzed by 4 analysts in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
<table>
<thead>
<tr>
<th></th>
<th align="right">Bullish</th>
<th align="right">Somewhat Bullish</th>
<th align="right">Indifferent</th>
<th align="right">Somewhat Bearish</th>
<th align="right">Bearish</th>
</tr>
</thead>
<tbody>
<tr>
<td>Total Ratings</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">2</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>Last 30D</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>1M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>2M Ago</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
<tr>
<td>3M Ago</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">1</td>
<td align="right">0</td>
<td align="right">0</td>
</tr>
</tbody>
</table>
Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $196.25, along with a high estimate of $222.00 and a low estimate of $170.00. Highlighting a 7.57% decrease, the current average has fallen from the previous average price target of $212.33. 
<img src="https://www.benzinga.com/files/images/story/2025/1744632054_0.png" alt="price target chart" />
<h2>Breaking Down Analyst Ratings: A Detailed Examination</h2>
The perception of AMETEK by financial experts is analyzed through recent analyst actions. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
&#x7C; Analyst &#x7C; Analyst Firm &#x7C; Action Taken &#x7C; Rating &#x7C;Current Price Target&#x7C; Prior Price Target &#x7C; 
&#x7C;--------------------&#x7C;--------------------&#x7C;---------------&#x7C;---------------&#x7C;--------------------&#x7C;--------------------&#x7C; 
&#x7C;Christopher Snyder &#x7C;Morgan Stanley &#x7C;Announces &#x7C;Equal-Weight &#x7C; $170.00&#x7C;- &#x7C; 
&#x7C;Jamie Cook &#x7C;Truist Securities &#x7C;Lowers &#x7C;Buy &#x7C; $196.00&#x7C;$216.00 &#x7C; 
&#x7C;Richard Eastman &#x7C;Baird &#x7C;Lowers &#x7C;Neutral &#x7C; $197.00&#x7C;$200.00 &#x7C; 
&#x7C;Jamie Cook &#x7C;Truist Securities &#x7C;Raises &#x7C;Buy &#x7C; $222.00&#x7C;$221.00 &#x7C;
<h3>Key Insights:</h3>
<ul>
<li>Action Taken: Responding to changing market dynamics and company performance, analysts update their recommendations. Whether they 'Maintain', 'Raise', or 'Lower' their stance, it signifies their response to recent developments related to AMETEK. This offers insight into analysts' perspectives on the current state of the company.</li>
<li>Rating: Providing a comprehensive analysis, analysts offer qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of AMETEK compared to the broader market.</li>
<li>Price Targets: Analysts set price targets as an estimate of a stock's future value. Comparing the current and prior price targets provides insight into how analysts' expectations have changed over time. This information can be valuable for investors seeking to understand consensus views on the stock's potential future performance.</li>
</ul>
Understanding these analyst evaluations alongside key financial indicators can offer valuable insights into AMETEK's market standing. Stay informed and make well-considered decisions with our Ratings Table.
<a href="https://www.benzinga.com/quote/AME/analyst-ratings?adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantage">Stay up to date on AMETEK analyst ratings.</a>
<h2>Unveiling the Story Behind AMETEK</h2>
Founded in 1930 and transformed over the decades through the acquisition of dozens of esteemed brands, Ametek owns a collection of over 40 autonomous industrial businesses operating within the research, aerospace, energy, medical, and manufacturing industries. Ametek segments its business into two operating groups: the electronic instruments group and the electromechanical group. The EIG sells a broad portfolio of analytical, test, and measurement instruments, while the EMG sells highly engineered components, interconnects, and specialty metals. The company emphasizes product differentiation and market leadership in the niche markets where it operates.
<h3>AMETEK: Financial Performance Dissected</h3>
Market Capitalization: Positioned above industry average, the company's market capitalization underscores its superiority in size, indicative of a strong market presence.
Revenue Growth: AMETEK's revenue growth over a period of 3M has been noteworthy. As of 31 December, 2024, the company achieved a revenue growth rate of approximately 1.77%. This indicates a substantial increase in the company's top-line earnings. When compared to others in the Industrials sector, the company faces challenges, achieving a growth rate lower than the average among peers.
Net Margin: AMETEK's net margin surpasses industry standards, highlighting the company's exceptional financial performance. With an impressive 21.98% net margin, the company effectively manages costs and achieves strong profitability.
Return on Equity (ROE): AMETEK's ROE stands out, surpassing industry averages. With an impressive ROE of 4.03%, the company demonstrates effective use of equity capital and strong financial performance.
Return on Assets (ROA): The company's ROA is a standout performer, exceeding industry averages. With an impressive ROA of 2.63%, the company showcases effective utilization of assets.
Debt Management: AMETEK's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 0.22.
<h2>Analyst Ratings: What Are They?</h2>
Benzinga tracks 150 analyst firms and reports on their stock expectations. Analysts typically arrive at their conclusions by predicting how much money a company will make in the future, usually the upcoming five years, and how risky or predictable that company's revenue streams are.
Analysts attend company conference calls and meetings, research company financial statements, and communicate with insiders to publish their ratings on stocks. Analysts typically rate each stock once per quarter or whenever the company has a major update.
Some analysts also offer predictions for helpful metrics such as earnings, revenue, and growth estimates to provide further guidance as to what to do with certain tickers. It is important to keep in mind that while stock and sector analysts are specialists, they are also human and can only forecast their beliefs to traders.
Breaking: Wall Street's Next Big Mover
Benzinga's #1 analyst just identified a stock poised for explosive growth. This under-the-radar company could surge 200%+ as major market shifts unfold. <a href="https://www.benzinga.com/premium/ideas/turning-point-trader-checkout-2/?t=Tu1tu3arja3be22tu36&amp;adType=benzinga-insights&amp;ad=analyst-ratings&amp;campaign=wallstreetadvantag">Click here for urgent details</a>.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Morgan Stanley analyst Christopher Snyder initiates coverage on AMETEK (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AME#NYSE">AME</a>) with a Equal-Weight rating and announces Price Target of $170.

Initiation

Morgan Stanley Initiates Coverage On AMETEK with Equal-Weight Rating, Announces Price Target of $170

ACVA

AEHL

ALIT

ALLE

BLNK

CHRW

CISS

CLVT

CRGO

CSLR

CTOS

EXPD

FBIN

FERG

FTAI

HAYW

HUBG

IPDN

JOBY

MATX

MGRC

MLKN

NVRI

PAYC

PAYX

PCTY

REZI

SCWO

SHLS

TREX

VCIG

VICR

VLTO

VSEC

VSTS

Shares of companies within the broader industrial sector are trading lower as stocks pull back after surging Wednesday following President Trump's tariff pause announcement.

AMRC

KRNT

LYTS

NDSN

NVEE

PPSI

ROAD

STRL

TGLS

Shares of machinery, electrical equipment and engineering companies are trading higher following President Trump's decision to implement a 90-day pause on reciprocal tariffs for all countries except China.

Commodities

Press Releases

AMETEK Appoints Isabel S. Wells Vice President, Information Technology and Chief Information Officer

Dividends

AMETEK Increases Quarterly Dividend and Announces $1.25 Billion Share Repurchase Authorization

Gabelli Funds to Host Pump, Valve & Water Systems Symposium at the Harvard Club, New York City

AMETEK Appoints Jennifer G. Hellberg Vice President, Human Resources

AMETEK Announces First Quarter 2025 Earnings Call and Webcasted Investor Conference Call Information

AMETEK Announces First Quarter Results

AMETEK to Acquire FARO Technologies

NYSE Content Advisory: Pre-Market update + Federal Reserve begins two-day policy meeting

AMETEK Declares Quarterly Dividend

FARO TECHNOLOGIES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of FARO Technologies, Inc. - FARO

Comments

AMETEK

Noticias

Últimas noticias sobre AMETEK (NYSE:AME) Bolsa

La gente también mira

Noticias

SOCIO/CONTRIBUIDOR

BENZINGA GLOBAL